Name | Number of supported studies | Average coverage | |
---|---|---|---|
mesothelial cell | 3 studies | 29% ± 13% |
Insufficient scRNA-seq data for expression of FZD7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 3321.34 | 244 / 245 | 95% | 29.49 | 479 / 502 |
ovary | 100% | 3775.07 | 180 / 180 | 94% | 37.45 | 406 / 430 |
breast | 96% | 2860.84 | 439 / 459 | 97% | 50.40 | 1081 / 1118 |
skin | 99% | 1975.97 | 1782 / 1809 | 88% | 43.63 | 413 / 472 |
esophagus | 97% | 3188.60 | 1399 / 1445 | 88% | 51.67 | 161 / 183 |
bladder | 100% | 5261.05 | 21 / 21 | 82% | 20.01 | 411 / 504 |
intestine | 97% | 4550.10 | 934 / 966 | 82% | 19.15 | 432 / 527 |
thymus | 95% | 1056.31 | 618 / 653 | 83% | 18.48 | 502 / 605 |
lung | 86% | 996.91 | 498 / 578 | 88% | 37.09 | 1019 / 1155 |
uterus | 100% | 3019.56 | 170 / 170 | 71% | 32.76 | 327 / 459 |
stomach | 68% | 862.58 | 244 / 359 | 84% | 23.74 | 241 / 286 |
kidney | 87% | 1380.39 | 77 / 89 | 57% | 10.95 | 511 / 901 |
brain | 49% | 1515.39 | 1303 / 2642 | 82% | 29.08 | 575 / 705 |
blood vessel | 99% | 1990.82 | 1320 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 5% | 27.84 | 15 / 328 | 93% | 21.17 | 165 / 178 |
adipose | 95% | 1516.23 | 1146 / 1204 | 0% | 0 | 0 / 0 |
heart | 89% | 1240.40 | 768 / 861 | 0% | 0 | 0 / 0 |
muscle | 83% | 1022.53 | 663 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 78% | 29.83 | 35 / 45 |
eye | 0% | 0 | 0 / 0 | 68% | 15.79 | 54 / 80 |
adrenal gland | 16% | 98.43 | 41 / 258 | 49% | 12.52 | 112 / 230 |
lymph node | 0% | 0 | 0 / 0 | 24% | 2.48 | 7 / 29 |
liver | 0% | 0 | 0 / 226 | 14% | 2.94 | 57 / 406 |
spleen | 12% | 68.69 | 30 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 1.88 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042327 | Biological process | positive regulation of phosphorylation |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_0060054 | Biological process | positive regulation of epithelial cell proliferation involved in wound healing |
GO_0060231 | Biological process | mesenchymal to epithelial transition |
GO_0048103 | Biological process | somatic stem cell division |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0042666 | Biological process | negative regulation of ectodermal cell fate specification |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0033077 | Biological process | T cell differentiation in thymus |
GO_2000726 | Biological process | negative regulation of cardiac muscle cell differentiation |
GO_0030182 | Biological process | neuron differentiation |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0034446 | Biological process | substrate adhesion-dependent cell spreading |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0019827 | Biological process | stem cell population maintenance |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0060071 | Biological process | Wnt signaling pathway, planar cell polarity pathway |
GO_0035567 | Biological process | non-canonical Wnt signaling pathway |
GO_0060828 | Biological process | regulation of canonical Wnt signaling pathway |
GO_0010812 | Biological process | negative regulation of cell-substrate adhesion |
GO_0014834 | Biological process | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0055038 | Cellular component | recycling endosome membrane |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0017147 | Molecular function | Wnt-protein binding |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_0005109 | Molecular function | frizzled binding |
GO_0042813 | Molecular function | Wnt receptor activity |
GO_0030165 | Molecular function | PDZ domain binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FZD7 |
Protein name | Frizzled-7 (Fz-7) (hFz7) (FzE3) |
Synonyms | |
Description | FUNCTION: Receptor for Wnt proteins. Most frizzled receptors are coupled to the beta-catenin canonical signaling pathway, which leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes. A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. Activation by WNT8 induces expression of beta-catenin target genes (By similarity). Following ligand activation, binds to CCDC88C/DAPLE which displaces DVL1 from FZD7 and leads to inhibition of canonical Wnt signaling, activation of G-proteins by CCDC88C and triggering of non-canonical Wnt responses . May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues. .; FUNCTION: (Microbial infection) Acts as a receptor for C.difficile toxin TcdB in the colonic epithelium. . |
Accessions | O75084 ENST00000286201.3 |